Non-human primate pharmacokinetics data suggests IBIO-600, a potentially best-in-class long-acting anti-myostatin antibody, could have a human half-life as long as…
04 March 2025 - Twenty-five teams of innovators from around the world, all using emerging technologies to accelerate sport’s contribution to…
January 15, 2025 16:05 ET | Source: Solid Biosciences Inc. - Duchenne: Dosed four patients in INSPIRE DUCHENNE clinical trial;…
New York, NY, Dec. 30, 2024 (GLOBE NEWSWIRE) -- Recently, the highly anticipated artificial intelligence blockchain project Eonday Coin (EYC)…